TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers June 30, 1978
TCL Archive Vince DeVita: Startup Funds For New Clinical Research Difficult To Get; Many Private Physicians More Capable Of Caring For Cancer Patients Than Those In Centers July 16, 1976
